Astellas Pharma buys OSI for $4 billion
- May 17, 2010
Astellas Pharma Inc., Japan’s No. 2 drug maker, said Monday it will buy U.S. cancer drug company OSI Pharmaceuticals Inc. for $4 billion in cash in a bid to expand its ... Read More
Astellas Pharma Inc., Japan’s No. 2 drug maker, said Monday it will buy U.S. cancer drug company OSI Pharmaceuticals Inc. for $4 billion in cash in a bid to expand its ... Read More
Phycal LLC has leased 2,800 square feet for an algae biotechnology laboratory at the BioResearch and Development Growth Park (BRDG) at the Danforth Plant Science Center. Phycal, led by President and ... Read More
Samsung said on May 11 that it plans to invest $20 billion in healthcare and green energy until 2020 in a move it says could provide thousands of new jobs. Among ... Read More
Abbott Laboratories announced late Tuesday that it had agreed to buy Facet Biotech for a net price of $450 million in cash, in a move aimed at expanding its drug pipeline, ... Read More
Akermin Inc. said Tuesday it raised $10 million in its Series B financing round and will use the new funds to develop and bring to market its carbon-capture system for power ... Read More